Clinical Trials

Showing 401 - 420 of 490 trials
Title Investigatorsort icon Disease(s)
A Pilot Study of a Geriatric-Specific Psychoeducational Intervention for Elderly Cancer Patients
[Protocol 09-116]
Roth, Andrew
  • Breast Cancer
  • Geriatrics
  • Prostate Cancer
    • Localized Disease
    • Quality of Life
  • Quality of Life
A Phase IB Study of MPDL3280A and Erlotinib in Patients with Advanced Non-Small Cell Lung Cancer
[Protocol 14-020]
Rudin, Charles
  • Lung Cancer, Non-Small Cell
A Phase I Study of GL-ONC1 for Treating Malignant Pleural Effusion
[Protocol 12-169]
Rusch, Valerie
  • Breast Cancer
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
  • Lung Cancer, Small Cell
  • Mesothelioma
A Phase I Study of TAS-102 plus CPT-11 (Irinotecan) in Patients with Advanced Digestive Cancers
[Protocol 13-105]
Saltz, Leonard
  • Colorectal Cancer
  • Upper Gastrointestinal
    • Gastric Cancer
Chemotherapy Alone or with Radiation Therapy for Treating Patients with Locally Advanced Rectal Cancer Undergoing Surgery
[Protocol 12-087]
Saltz, Leonard
  • Colorectal Cancer
    • Rectal Cancer
A Phase I Study of High-Dose Therapy and Autologous Stem Cell Transplantation Followed by Modified T Cells for Aggressive B-Cell Non-Hodgkin Lymphoma
Relapsed/Refractory
[Protocol 12-117]
Sauter, Craig
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Study of Allogeneic Stem Cell Transplantation in HIV-Infected Patients with Hematologic Cancers
[Protocol 12-092]
Sauter, Craig
  • Blood and Marrow Transplantation
    • Transplantation
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
    • Myelodysplastic Syndrome
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
A Phase III Study of Cabozantinib (XL184) versus Mitoxantrone/Prednisone in Men with Previously Treated Symptomatic Castration-Resistant Prostate Cancer
[Protocol 12-032]
Scher, Howard
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
    • Quality of Life
A Phase II Study of Abiraterone, Prednisone, and Degarelix in Men with Recurrent Prostate Cancer and a Rising PSA
[Protocol 12-187]
Scher, Howard
  • Prostate Cancer
    • Rising PSA After Primary Therapy
A Study Assessing the Use of Serial FLT PET/CT Imaging to Monitor Response to Therapy in People with Cancer
Relapsed/Refractory
[Protocol 14-050]
Schoder, Heiko
  • Solid Tumors
A Phase I Study of MEDI4736 in Patients with Advanced Solid Tumors
[Protocol 12-179]
Segal, Neil
  • Colorectal Cancer
  • Kidney Cancer
  • Lung Cancer, Non-Small Cell
  • Melanoma
A Phase I Study of PF-05082566 Alone in Patients with Advanced Cancer, and in Combination with Rituximab in Patients with Non-Hodgkin Lymphoma
[Protocol 11-085]
Segal, Neil
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I Study of Lirilumab plus Nivolumab in Patients with Advanced Solid Tumors
[Protocol 12-224]
Segal, Neil
  • Colorectal Cancer
  • Kidney Cancer
  • Lung Cancer, Non-Small Cell
  • Melanoma
  • Ovarian Cancer
A Phase I Study of Whole Brain Radiation Therapy plus Sorafenib for Patients with Breast Cancer Brain Metastases
[Protocol 12-046]
Seidman, Andrew
  • Brain Tumors, Metastatic
  • Breast Cancer
A Phase II Study of Concurrent Intensity-Modulated Radiation Therapy (IMRT), Paclitaxel, and Pazopanib/Placebo for the Treatment of Anaplastic Thyroid Cancer
[Protocol 10-186]
Sherman, Eric
  • Thyroid Cancer
A Phase I Study of Dabrafenib plus Lapatinib to Treat Inoperable Thyroid Cancers with Abnormal BRAF
[Protocol 13-061]
Sherman, Eric
  • Thyroid Cancer
A Phase III Study of Vandetanib in Patients with Locally Advanced or Metastatic Papillary Thyroid Cancer Who Cannot Be Successfully Treated with Radioiodine
[Protocol 13-245]
Sherman, Eric
  • Thyroid Cancer
A Phase I Study of EPZ-5676 to Treat Children with Recurrent or Persistent MLL-Mutant Acute Leukemia
Relapsed/Refractory
[Protocol 14-080]
Shukla, Neerav
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
Treatment of Patients with Newly Diagnosed Standard Risk B-precursor Acute Lymphoblastic Leukemia
[Protocol 11-002]
Shukla, Neerav
  • Leukemia
    • Acute Lymphoblastic Leukemia
A Phase II Study of Dasatinib in Children and Adolescents Newly Diagnosed with Chronic Phase CML or with Philadelphia Chromosome-Positive Leukemias Resistant to or Intolerant of Imatinib
[Protocol 11-030]
Shukla, Neerav
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Chronic Myelocytic Leukemia